Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iSPOT-A: Methylphenidate Response Prediction in ADHD
NCT00863499Phase 4Unknown
- Sponsor
- Biopharmaceutical Research Company
- Start
- Oct 2009
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Biopharmaceutical Research Company. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00863499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863499.